ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
RIGL holding history
Rigel Pharmaceuticals Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −3,075−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q1 2024 | 30,746 | $45.5K | <0.1% | +2,421+8.5% | Added | Holders |
| Q4 2023 | 28,325 | $41.1K | <0.1% | +6,091+27.4% | Added | Holders |
| Q3 2023 | 22,234 | $24.0K | <0.1% | −23−0.1% | Reduced | Holders |
| Q2 2023 | 22,257 | $28.7K | <0.1% | +1,947+9.6% | Added | Holders |
| Q1 2023 | 20,310 | $26.8K | <0.1% | −1,895−8.5% | Reduced | Holders |
| Q4 2022 | 22,205 | $33.3K | <0.1% | −11,354−33.8% | Reduced | Holders |
| Q3 2022 | 33,559 | $40.0K | <0.1% | +774+2.4% | Added | Holders |
| Q2 2022 | 32,785 | $37.0K | <0.1% | −16,946−34.1% | Reduced | Holders |
| Q1 2022 | 49,731 | $149.0K | <0.1% | −11,678−19.0% | Reduced | Holders |
| Q4 2021 | 61,409 | $163.0K | <0.1% | +3,018+5.2% | Added | Holders |
| Q3 2021 | 58,391 | $212.0K | <0.1% | −16,510−22.0% | Reduced | Holders |
| Q2 2021 | 74,901 | $325.0K | <0.1% | +6,170+9.0% | Added | Holders |
| Q1 2021 | 68,731 | $235.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.